Common Gut Problems in MS: What Patients Should Know

Common Gut Problems in MS: What Patients Should Know
Credibility
Interest
Share:2 min read
Key Takeaway

Gut problems like swallowing trouble and bowel issues are common in people with MS and often come from nerve-related gut control, so checking for these problems should be part of routine care.

What They Found

Researchers looked at 114 studies with over 1.2 million people with MS and found gut problems are common. About one-third of people with MS had signs of the gut's nerves not working well (autonomic GI dysfunction), which means the nerves that help move food and control bladder/bowel may be affected. Trouble swallowing (dysphagia) and bowel problems like constipation or incontinence were especially common. Lower gut problems (like bowel trouble) were more frequent than upper gut problems (like stomach issues). Compared with people without MS, those with MS had much higher chances of having nerve-related gut problems, but study methods varied a lot so numbers are broad estimates.

Who Should Care and Why

People with MS should care because gut problems can make daily life harder, for example making eating, sleeping, or leaving the house more difficult. Caregivers should watch for signs like coughing while eating, frequent constipation, or unexpected bowel accidents because these may need medical attention. Doctors and nurses should include basic gut checks in regular MS visits, like asking about swallowing, constipation, or bowel control, because early help can prevent complications. Physical therapists, speech therapists, and dietitians can help — for example a swallow therapist can teach safer swallowing tricks, like tucking the chin while swallowing. Knowing these problems are common helps patients and caregivers ask for help sooner, rather than thinking the symptoms are just part of aging.

Important Considerations

The studies used many different ways to measure gut problems, so the exact numbers vary and should be seen as general estimates rather than exact counts. Most studies did not use the same tests or definitions, which makes it hard to say precisely who will get which problem. This means you should talk with your healthcare team about your own risk and symptoms instead of relying only on these averages.

AI-generated summary — for informational purposes only, not medical advice

Article Topics:
Autonomic dysfunctionGastrointestinalMeta-analysisMultiple sclerosisSystematic review

You May Also Like

Gut Bacteria and MS: What You Need to Know
Gut Bacteria and MS: What You Need to Know

12/31/2026

Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li

Read More
Clear gut bacteria clues for MS — what it means today
Clear gut bacteria clues for MS — what it means today

12/31/2026

Researchers found consistent gut bacteria differences in MS tied to disease type, treatment response

Read More
How the Brain Saves Energy: Possible Clues for MS Care
How the Brain Saves Energy: Possible Clues for MS Care

10/1/2026

Study finds different brain cells use unique ways to survive low-energy states; this could inspire f

Read More
Rare nerve-only autoimmune signs tied to Ma/Ma2 cancer
Rare nerve-only autoimmune signs tied to Ma/Ma2 cancer

9/1/2026

A small study found Ma/Ma2 antibodies can cause nerve-only symptoms often linked to cancer; testing

Read More
Ravulizumab cuts relapses in AQP4+ NMO long-term for patients
Ravulizumab cuts relapses in AQP4+ NMO long-term for patients

9/1/2026

Long-term study shows ravulizumab greatly reduced relapses in AQP4+ NMOSD over 3+ years with expecte

Read More
Double-Negative NMOSD: Risks and Early Treatment Now
Double-Negative NMOSD: Risks and Early Treatment Now

9/1/2026

Even without common antibodies, NMOSD can be severe and relapsing; early maintenance immune treatmen

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.